v3.25.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2025
Income Taxes  
Summary of reconciliation of federal statutory income tax rate to the Company's effective income tax rate

The reconciliation of federal statutory income tax rate to the Company’s effective income tax rate for the year ended December 31, 2025 is as follows:

December 31, 

 

  ​ ​ ​

Amount

  ​ ​ ​

Percent

Expected income tax benefit at the federal statutory rate

$

(11,727)

21.0

%

State taxes, net of federal benefit

 

(3,649)

6.5

Research and development credit, net

 

(1,393)

2.5

Other

 

175

(0.3)

Change in valuation allowance

 

16,594

(29.7)

Total

$

%

The reconciliation of federal statutory income tax rate to the Company’s effective income tax rate for the year ended December 31, 2024 is as follows:

December 31, 

  ​ ​ ​

2024

  ​ ​ ​

Expected income tax benefit at the federal statutory rate

 

21.0

%  

State taxes, net of federal benefit

 

6.6

 

Research and development credit, net

 

4.0

 

Non-deductible items

 

(0.6)

 

Other

 

(1.6)

 

Change in valuation allowance

 

(29.4)

 

Total

 

%  

Summary of components of deferred tax assets

The principal components of the Company’s deferred tax assets consisted of the following as of December 31, 2025 and 2024:

December 31, 

(in thousands)

  ​ ​ ​

 

2025

  ​ ​ ​

 

2024

Deferred tax assets:

 

  ​

 

  ​

Federal and state net operating loss carryforwards

 

$

85,836

 

$

63,647

Research and development tax credits

17,829

16,436

Capitalized R&D Costs

18,271

25,826

Operating lease liabilities

1,419

1,642

Share-based compensation

8,032

7,234

Accruals and other

1,415

1,587

Gross deferred tax assets

132,802

116,372

Less: valuation allowance

(131,903)

(115,309)

Total deferred tax assets

 

$

899

 

$

1,063

Deferred tax liabilities:

Operating lease assets

(899)

(1,063)

Gross deferred tax liabilities

 

$

(899)

 

$

(1,063)

Net deferred tax assets

 

$

 

$